相关实验视频

Updated: Jul 1, 2026

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

通过TMS-EEG扰动复杂性指数评估阿尔茨海默病

Brenna Hagan1,2, Stephanie S Buss3, Peter J Fried3

  • 1Center for Translational Cognitive Neuroscience, VA Boston Healthcare System, 150 S. Huntington Ave, Boston, MA 02130, United States.

Neuroscience of consciousness
|January 23, 2026
PubMed
概括

这就是阿尔茨海默病的原因.

关键词:
阿尔茨海默氏症的疾病是阿尔茨海默氏症.意识意识意识意识意识意识意识意识意识意识意识神经学 神经学这是PCI的PCI.这就是TMS-EEG.

更多相关视频

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke06:37

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke

Published on: July 14, 2023

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping09:55

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping

Published on: June 13, 2025

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...